ECE2010 Poster Presentations Female reproduction (44 abstracts)
AMH secretion seems not to be influenced by acute GnRH-analogue administration in PCOS patients
Roberto Mioni 1 , Rosa Ritunnano 1 , Chiara Cosma 2 , Laura Zuliani 1 , Letizia Glinski 1 , Sara Azzolini 1 , Luigi Bleve 1 , Marnie Granzotto 1 , Piero Maffei 1 , Diego Faggian 2 , Nicola Sicolo 1 & Roberto Vettor 1
1Medical and Surgical Sciences Department-Clinica Medica 3, University-Hospital of Padua, Padua, Italy; 2Laboratory Medicine Department, University-Hospital of Padua, Padua, Jamaica.
Background: Hyperandrogenism and disrupted folliculogenesis are prominent features of polycystic ovary syndrome (PCOS) and are causatively linked to ovarian dysfunction. In PCOS, increased anti-Müllerian hormone (AMH) serum levels have been observed and related to the severity of the phenotype. However, the regulation of AMH in PCOS remains poorly understood. Therefore, we compared AMH secretory pattern after acute exposure to a GnRH-analogue in women affected by PCOS or by other causes of anovulation and hyperandrogenism, such as functional hypothalamic amenorrhea (FHA) and extra-ovarian hyperandrogenaemia (non-PCOSH).
Patients and methods: Of 26 PCOS (23.9±4.8 years), 9 FHA (26.6±2.6 years) and 8 non-PCOSH (21.2±4.5 years) women were studied. Testing was performed at 4–7 day/cycle, after Liddle test. AMH, LH, FSH, DHEA-S, 17-OHP, A, T, DHT, E2, Inh-B were evaluated at 0-h, and over a 20 and 24-h period after a s.c. injection of Triptorelin (0.1 mg).
Results: Our results are summarized in Table:
| PCOS | FHA | Non-PCOSH | ||||
| Baseline | Peak | Baseline | Peak | Baseline | Peak | |
| E2 (pM) | 160±67 | 1546±675 | 76±27* | 1453±350 | 123±36 | 1056±537 |
| InhB (ng/l) | 114±40 | 400±121 | 154±43 | 566±100 | 81±24.6 | 205±97‡ |
| AMH (pM) | 43±18 | 44±14§ | 70±26* | 78±44†,§ | 21±10*,† | 24±12‡,§ |
| *P<0.05 versus PCOS baseline; †P<0.05 versus FHA baseline; ‡P<0.05 versus PCOS peak; §NS versus baseline values. | ||||||
Conclusions: AMH serum levels were increased in PCOS and FHA patients when compared with non-PCOSH subjects, suggesting that extra-ovarian androgens may not be directly involved in the complex AMH regulation network. In contrast with conventional markers of early follicular growth, such as inhibin-B and E2, AMH secretion appears to be independent of gonadotropin acute stimulation in vivo both in PCOS and non-PCOS patients.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more